NextCure (NXTC)
(Delayed Data from NSDQ)
$1.41 USD
+0.04 (2.92%)
Updated Sep 26, 2024 04:00 PM ET
After-Market: $1.41 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value B Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | -0.35 |
EPS Last Quarter | -0.55 |
Last EPS Surprise | -52.78% |
ABR | 1.75 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.79 |
Next Year | -1.64 |
EPS (TTM) | -2.19 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.35 | -0.37 | -1.79 | -1.64 |
# of Estimates | 2 | 2 | 3 | 3 |
Most Recent Consensus | -0.37 | -0.38 | -1.74 | -2.03 |
High Estimate | -0.32 | -0.35 | -1.74 | -1.41 |
Low Estimate | -0.37 | -0.38 | -1.84 | -2.03 |
Year ago EPS | -0.51 | -0.52 | -2.25 | -1.79 |
Year over Year Growth Est. | 31.37% | 28.85% | 20.44% | 8.01% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.35 | -0.37 | -1.79 | -1.64 |
7 Days Ago | -0.35 | -0.37 | -1.79 | -1.64 |
30 Days Ago | -0.35 | -0.37 | -1.79 | -1.64 |
60 Days Ago | -0.35 | -0.37 | -1.71 | -1.64 |
90 Days Ago | -0.35 | -0.37 | -1.71 | -1.64 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.35 | -0.37 | -1.79 | -1.64 |
Zacks Consensus Estimate | -0.35 | -0.37 | -1.79 | -1.64 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.55 | -0.61 | -0.52 | -0.51 | NA |
Estimate | -0.36 | -0.45 | -0.54 | -0.64 | NA |
Difference | -0.19 | -0.16 | 0.02 | 0.13 | -0.05 |
Surprise | -52.78% | -35.56% | 3.70% | 20.31% | -16.08% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more